RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies

This study has been completed.
Sponsor:
Information provided by:
Reata Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00529438
First received: September 12, 2007
Last updated: December 19, 2008
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given